Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study

PURPOSE: In PALOMA-2, palbociclib plus letrozole significantly improved progression-free survival (PFS) as initial treatment of estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer. We assessed the benefit of palbociclib plus letrozole in Asians. PATIEN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Glob Oncol
Main Authors: Im, Seock-Ah, Mukai, Hirofumi, Park, In Hae, Masuda, Norikazu, Shimizu, Chikako, Kim, Sung-Bae, Im, Young-Hyuck, Ohtani, Shoichiro, Huang Bartlett, Cynthia, Lu, Dongrui R., Iyer, Shrividya, Mori, Yuko, Mori, Ave, Gauthier, Eric, Finn, Richard S., Toi, Masakazu
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORT
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6550032/
https://ncbi.nlm.nih.gov/pubmed/31125276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.18.00173
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados